These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 6401163

  • 1. Mutagen treatment as a means for selecting immunogenic variants from otherwise poorly immunogenic malignant murine tumors.
    Frost P, Kerbel RS, Bauer E, Tartamella-Biondo R, Cefalu W.
    Cancer Res; 1983 Jan; 43(1):125-32. PubMed ID: 6401163
    [No Abstract] [Full Text] [Related]

  • 2. Selection of strongly immunogenic "tum-" variants from tumors at high frequency using 5-azacytidine.
    Frost P, Liteplo RG, Donaghue TP, Kerbel RS.
    J Exp Med; 1984 May 01; 159(5):1491-501. PubMed ID: 6201588
    [Abstract] [Full Text] [Related]

  • 3. Correlation of frequency of induced mutation and metastatic potential in tumor cell lines from a single mouse mammary tumor.
    Yamashina K, Heppner GH.
    Cancer Res; 1985 Sep 01; 45(9):4015-9. PubMed ID: 4027998
    [Abstract] [Full Text] [Related]

  • 4. The delayed and lasting rejection of mammary adenocarcinoma cell tumors in DBA-2 mice with use of killed Bordetella pertussis.
    Likhite VV.
    Cancer Res; 1974 May 01; 34(5):1027-30. PubMed ID: 4363061
    [No Abstract] [Full Text] [Related]

  • 5. The prevalence of ouabain-resistant variants after mutagen treatment. Lack of correlation between the frequency of variant expression and the metastatic phenotype.
    Frost P, Kendal W, Hunt B, Ellis M.
    Invasion Metastasis; 1988 May 01; 8(2):73-86. PubMed ID: 3360593
    [Abstract] [Full Text] [Related]

  • 6. Antigen specificity and immunogenic capacity of 3m KCl cell extracts from ascites tumour ATPCplus.
    Marconi P, Bistoni F, Pitzurra M.
    Boll Ist Sieroter Milan; 1974 May 01; 53(2):377-91. PubMed ID: 4214542
    [No Abstract] [Full Text] [Related]

  • 7. Immune responsiveness to a murine mammary carcinoma modified to express B7-1, interleukin-12, or GM-CSF.
    Aruga E, Aruga A, Arca MJ, Lee WM, Yang NS, Smith JW, Chang AE.
    Cancer Gene Ther; 1997 May 01; 4(3):157-66. PubMed ID: 9171934
    [Abstract] [Full Text] [Related]

  • 8. Experimental evaluation of in situ oncocide for primary tumor therapy: comparison of tumor-specific immunity after complete excision, cryonecrosis and ligation.
    Neel HB, Ketcham AS, Hammond WG.
    Laryngoscope; 1973 Mar 01; 83(3):376-87. PubMed ID: 4690029
    [No Abstract] [Full Text] [Related]

  • 9. Interferon-inducibility is diminished in tumour-bearing mice.
    Hung PL, Stöger I, Karczag E, Minárovics J, Földes I.
    Acta Microbiol Hung; 1989 Mar 01; 36(4):433-8. PubMed ID: 2484273
    [Abstract] [Full Text] [Related]

  • 10. Synergism between host anti-tumor immunity and combined modality therapy against murine breast cancer.
    Stolfi RL, Fugmann RA, Stolfi LM, Martin DS.
    Int J Cancer; 1974 Mar 15; 13(3):389-403. PubMed ID: 4822108
    [No Abstract] [Full Text] [Related]

  • 11. The cytotoxic T-lymphocyte response against a poorly immunogenic mammary adenocarcinoma is focused on a single immunodominant class I epitope derived from the gp70 Env product of an endogenous retrovirus.
    Rosato A, Dalla Santa S, Zoso A, Giacomelli S, Milan G, Macino B, Tosello V, Dellabona P, Lollini PL, De Giovanni C, Zanovello P.
    Cancer Res; 2003 May 01; 63(9):2158-63. PubMed ID: 12727834
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
    Rakhmilevich AL, Janssen K, Hao Z, Sondel PM, Yang NS.
    Cancer Gene Ther; 2000 Jun 01; 7(6):826-38. PubMed ID: 10880012
    [Abstract] [Full Text] [Related]

  • 13. Immune response to inactivated syngeneic mammary adenocarcinoma cells. II. Parameters of immunogenicity in DBA/2 mice.
    DeLustro F, Haskill JS.
    J Natl Cancer Inst; 1980 Jan 01; 64(1):131-7. PubMed ID: 6928038
    [No Abstract] [Full Text] [Related]

  • 14. A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions.
    Giovarelli M, Musiani P, Garotta G, Ebner R, Di Carlo E, Kim Y, Cappello P, Rigamonti L, Bernabei P, Novelli F, Modesti A, Coletti A, Ferrie AK, Lollini PL, Ruben S, Salcedo T, Forni G.
    J Immunol; 1999 Nov 01; 163(9):4886-93. PubMed ID: 10528190
    [Abstract] [Full Text] [Related]

  • 15. Enhanced cures of spontaneous murine mammary carcinomas with surgery and five-compound combination chemotherapy, and their immunotherapeutic interrelationship.
    Fugmann RA, Martin DS, Hayworth PE, Stolfi RL.
    Cancer Res; 1970 Jul 01; 30(7):1931-6. PubMed ID: 5456078
    [No Abstract] [Full Text] [Related]

  • 16. Interaction of H-2 and non-H-2 genes in spontaneous resistance to adenocarcinoma ADK-1t in F1 mice.
    Forni G, Serrati G, Giordano L, Giovarelli M, Rendine S, Landolfo S.
    J Natl Cancer Inst; 1980 Sep 01; 65(3):651-5. PubMed ID: 6931938
    [Abstract] [Full Text] [Related]

  • 17. Effect of C. parvum on intratumor immunity to the T1699 mammary adenocarcinoma.
    Haskill S, Ritter F, Becker S.
    J Immunol; 1980 Jul 01; 125(1):454-8. PubMed ID: 6247400
    [No Abstract] [Full Text] [Related]

  • 18. Mutagenesis in S49 mouse lymphoma cells: induction of resistance to ouabain, 6-thioguanine, and dibutyryl cyclic AMP.
    Friedrich U, Coffino P.
    Proc Natl Acad Sci U S A; 1977 Feb 01; 74(2):679-83. PubMed ID: 191823
    [Abstract] [Full Text] [Related]

  • 19. Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma.
    Morecki S, Yacovlev E, Gelfand Y, Uzi I, Slavin S.
    J Immunother; 2001 Feb 01; 24(2):114-21. PubMed ID: 11265768
    [Abstract] [Full Text] [Related]

  • 20. Circulating immune complexes in rats bearing 6-thioguanine-resistant variants of the 13762 mammary adenocarcinoma.
    Hoon DB, Ziola B, Ramshaw I.
    Cancer Res; 1984 Jun 01; 44(6):2406-9. PubMed ID: 6722781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.